IL164755A0 - Pharmaceutical composition containing a reversibleprotein pump inhibitor - Google Patents
Pharmaceutical composition containing a reversibleprotein pump inhibitorInfo
- Publication number
- IL164755A0 IL164755A0 IL16475504A IL16475504A IL164755A0 IL 164755 A0 IL164755 A0 IL 164755A0 IL 16475504 A IL16475504 A IL 16475504A IL 16475504 A IL16475504 A IL 16475504A IL 164755 A0 IL164755 A0 IL 164755A0
- Authority
- IL
- Israel
- Prior art keywords
- reversibleprotein
- pharmaceutical composition
- composition containing
- pump inhibitor
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02010305 | 2002-05-07 | ||
PCT/EP2003/004653 WO2003094967A2 (en) | 2002-05-07 | 2003-05-03 | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164755A0 true IL164755A0 (en) | 2005-12-18 |
Family
ID=29414673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16475504A IL164755A0 (en) | 2002-05-07 | 2004-10-21 | Pharmaceutical composition containing a reversibleprotein pump inhibitor |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050222193A1 (xx) |
EP (1) | EP1506016A2 (xx) |
JP (1) | JP2005528418A (xx) |
KR (1) | KR20050007476A (xx) |
CN (1) | CN1652822A (xx) |
AU (1) | AU2003227710A1 (xx) |
BR (1) | BR0309808A (xx) |
CA (1) | CA2484272A1 (xx) |
EA (1) | EA200401454A1 (xx) |
HR (1) | HRP20041160A2 (xx) |
IL (1) | IL164755A0 (xx) |
MX (1) | MXPA04011018A (xx) |
NO (1) | NO20045343L (xx) |
PL (1) | PL373287A1 (xx) |
RS (1) | RS95304A (xx) |
WO (1) | WO2003094967A2 (xx) |
ZA (1) | ZA200407896B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1453493A2 (en) * | 2001-11-19 | 2004-09-08 | ALTANA Pharma AG | Reversible proton pump inhibitors for the treatment of airway disorders |
SE0303451D0 (sv) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
AU2005237246A1 (en) * | 2004-04-30 | 2005-11-10 | Nycomed Gmbh | Method of classifying GERD |
CA2582300A1 (en) * | 2004-10-05 | 2006-04-13 | Altana Pharma Ag | Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
CA2997471C (en) | 2010-11-16 | 2020-12-01 | Texas Heart Institute | Agonists that enhance binding of integrin-expressing cells to integrin receptors |
KR101873530B1 (ko) * | 2012-04-10 | 2018-07-02 | 삼성전자주식회사 | 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법 |
JO3737B1 (ar) * | 2015-07-21 | 2021-01-31 | Athenex Therapeutics Ltd | تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
SI0706513T1 (en) * | 1993-07-02 | 2002-10-31 | Altana Pharma Ag | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
DE19541689A1 (de) * | 1994-11-14 | 1996-05-15 | Byk Gulden Lomberg Chem Fab | Kombinationsarzneimittel |
NZ298853A (en) * | 1995-01-27 | 1998-07-28 | Rhone Poulenc Rorer Ltd | 5-[2-cyano-phenoxy]-2-phenyl-acetic acid derivatives |
WO1996041626A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
EP0852498A1 (en) * | 1995-09-26 | 1998-07-15 | Takeda Chemical Industries, Ltd. | Phosphorylamides, their preparation and use |
US6599927B2 (en) * | 1996-10-11 | 2003-07-29 | Astrazeneca Ab | Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome |
SE9603725D0 (sv) * | 1996-10-11 | 1996-10-11 | Astra Ab | New teatment |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
AU9067198A (en) * | 1997-07-25 | 1999-02-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Proton pump inhibitor in therapeutic combination with antibacterial substances |
US6060472A (en) * | 1998-04-06 | 2000-05-09 | Apotex Inc. | Thiadiazole compounds useful as inhibitors of H+ /K+ atpase |
JP2002523452A (ja) * | 1998-08-26 | 2002-07-30 | スミスクライン・ビーチャム・コーポレイション | 肺疾患の治療方法 |
DE69905178T2 (de) * | 1998-09-23 | 2003-07-17 | Altana Pharma Ag | Tetrahydropyridoether |
GB9911017D0 (en) * | 1999-05-13 | 1999-07-14 | Zeneca Ltd | Pharmaceutical compositions |
NZ520837A (en) * | 2000-03-29 | 2005-01-28 | Altana Pharma Ag | Prodrugs of imidazopyridine derivatives |
DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US6528527B2 (en) * | 2000-11-07 | 2003-03-04 | Merck & Co., Inc. | Method of treatment with a combination of a PDE4 inhibitor and a leukotriene antagonist |
EP1453493A2 (en) * | 2001-11-19 | 2004-09-08 | ALTANA Pharma AG | Reversible proton pump inhibitors for the treatment of airway disorders |
-
2003
- 2003-05-03 AU AU2003227710A patent/AU2003227710A1/en not_active Abandoned
- 2003-05-03 JP JP2004503050A patent/JP2005528418A/ja active Pending
- 2003-05-03 EA EA200401454A patent/EA200401454A1/ru unknown
- 2003-05-03 PL PL03373287A patent/PL373287A1/xx not_active Application Discontinuation
- 2003-05-03 CN CNA038104008A patent/CN1652822A/zh active Pending
- 2003-05-03 EP EP03725140A patent/EP1506016A2/en not_active Withdrawn
- 2003-05-03 BR BR0309808-7A patent/BR0309808A/pt not_active IP Right Cessation
- 2003-05-03 KR KR10-2004-7017820A patent/KR20050007476A/ko not_active Application Discontinuation
- 2003-05-03 CA CA002484272A patent/CA2484272A1/en not_active Abandoned
- 2003-05-03 RS YU95304A patent/RS95304A/sr unknown
- 2003-05-03 MX MXPA04011018A patent/MXPA04011018A/es unknown
- 2003-05-03 US US10/513,598 patent/US20050222193A1/en not_active Abandoned
- 2003-05-03 WO PCT/EP2003/004653 patent/WO2003094967A2/en active Application Filing
-
2004
- 2004-09-30 ZA ZA200407896A patent/ZA200407896B/en unknown
- 2004-10-21 IL IL16475504A patent/IL164755A0/xx unknown
- 2004-12-06 HR HR20041160A patent/HRP20041160A2/xx not_active Application Discontinuation
- 2004-12-06 NO NO20045343A patent/NO20045343L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050007476A (ko) | 2005-01-18 |
WO2003094967A2 (en) | 2003-11-20 |
US20050222193A1 (en) | 2005-10-06 |
MXPA04011018A (es) | 2005-01-25 |
HRP20041160A2 (en) | 2005-08-31 |
PL373287A1 (en) | 2005-08-22 |
AU2003227710A1 (en) | 2003-11-11 |
BR0309808A (pt) | 2005-03-01 |
NO20045343L (no) | 2004-12-06 |
JP2005528418A (ja) | 2005-09-22 |
EA200401454A1 (ru) | 2005-06-30 |
CN1652822A (zh) | 2005-08-10 |
CA2484272A1 (en) | 2003-11-20 |
RS95304A (xx) | 2006-12-15 |
ZA200407896B (en) | 2006-06-28 |
WO2003094967A3 (en) | 2004-04-01 |
EP1506016A2 (en) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0218625D0 (en) | Pharmaceutical compounds | |
PL360967A1 (en) | Pharmaceutical compound containing donepezyl hydrochloride | |
AU2003291103A8 (en) | Pharmaceutical composition | |
AU2003276549A8 (en) | Pharmaceutical compositions containing a biguanide-glitazone combination | |
IL164547A0 (en) | Pharmaceutical composition | |
IL158083A0 (en) | A PHARMACEUTICAL COMPOSITION CONTAINING AN Eg5 PROTEIN INHIBITOR | |
AU2003250372A8 (en) | Pharmaceutical composition | |
GB0215775D0 (en) | Pharmaceutical compounds | |
GB0220448D0 (en) | Fluid dispenser | |
EP1541139A4 (en) | DRUG COMPOSITION WITH NF-KAPPA B HEMMER | |
IL164755A0 (en) | Pharmaceutical composition containing a reversibleprotein pump inhibitor | |
GB0227173D0 (en) | Dispensing pump | |
GB0206343D0 (en) | Fluid dispenser | |
AU2003291642A8 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
HK1065477A1 (en) | Pharmaceutical composition | |
AU2003208621A1 (en) | A pharmaceutical composition | |
AU2003283218A8 (en) | Fluid dispenser | |
GB0204392D0 (en) | Pharmaceutical compound | |
IL164756A0 (en) | Pharmaceutical compositions containing protein pump inhibitors | |
HU0200337D0 (en) | Stabilised pharmaceutical composition | |
HU0300070V0 (en) | Fluid dispenser | |
GB0217703D0 (en) | Pharmaceutical composition | |
GB0212462D0 (en) | Pharmaceutical compound | |
GB0204391D0 (en) | Pharmaceutical compound | |
GB0212459D0 (en) | Pharmaceutical compound |